Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Van Haren, Simon D ^a   Wroblewska, Aleksandra ^a   Herczenik, Eszter ^a   Kaijen, Paul H ^a   Ruminska, Aleksandra ^a   Ten Brinke, Anja ^b   Meijer, Alexander B ^a,c   Voorberg, Jan ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; EPITOPES; EPITOPES, T-LYMPHOCYTE; FACTOR VIII; HLA-DRB1 CHAINS; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84893526037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080239     Document Type: Article

References (40)

1. Reding MT, Lei S, Lei H, Green D, Gill J et al. (2002) Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost 88: 568-575. PubMed: 12362225. (Pubitemid 35173996)
2. Ettinger RA, James EA, Kwok WW, Thompson AR, Pratt KP (2009) Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses. Blood 114: 1423-1428. doi:10.1182/blood-2009-01-200725. PubMed: 19549986.
3. Pavlova A, Delev D, Lacroix-Desmazes S, Schwaab R, Mende M et al. (2009) Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A. J Thromb Haemost 7: 2006-2015. doi:10.1111/j.1538-7836.2009.03636.x. PubMed: 19817985.
4. Howson JM, Stevens H, Smyth DJ, Walker NM, Chandler KA et al. (2011) Evidence that HLA Class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 60: 2635-2644. doi:10.2337/db11-0131. PubMed: 21831970.
5. Smolen JS, Klippel JH, Penner E, Reichlin M, Steinberg AD et al. (1987) HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 46: 457-462. doi:10.1136/ard.46.6.457. PubMed: 3498447. (Pubitemid 17129918)
6. Blackwell JM, Jamieson SE, Burgner D (2009) HLA and infectious diseases. Clin Microbiol Rev 22: 370-385, Table of Contents doi:10.1128/CMR.00048-08. PubMed: 19366919.
7. Wang SF, Chen KH, Chen M, Li WY, Chen YJ et al. (2011) Humanleukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol 24: 421-426. doi:10.1089/vim.2011.0024. PubMed: 21958371.
8. van Haren SD, Herczenik E, ten Brinke A, Mertens K, Voorberg J et al. (2011) HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII. Mol Cell Proteomics 10: 002246 21467215.
9. Dasgupta S, Navarrete AM, Bayry J, Delignat S, Wootla B et al. (2007) A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proc Natl Acad Sci U S A 104: 8965-8970. doi:10.1073/pnas.0702120104. PubMed: 17502612. (Pubitemid 47175420)
10. Navarrete A, Dasgupta S, Delignat S, Caligiuri G, Christophe OD et al. (2009) Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A. J Thromb Haemost 7: 1816-1823. doi:10.1111/j.1538-7836.2009.03571.x. PubMed: 19682235.
11. Reding MT, Okita DK, Diethelm-Okita BM, Anderson TA, Conti-Fine BM (2004) Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII. J Thromb Haemost 2: 1385-1394. doi:10.1111/j.1538-7836.2004.00850. x. PubMed: 15304045. (Pubitemid 40186136)
12. Reding MT, Okita DK, Diethelm-Okita BM, Anderson TA, Conti-Fine BM (2003) Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII. J Thromb Haemost 1: 1777-1784. doi:10.1046/j. 1538-7836.2003.00251.x. PubMed: 12911593.
13. Reding MT, Wu H, Krampf M, Okita DK, Diethelm-Okita BM et al. (1999) CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects. Thromb Haemost 82: 509-515. PubMed: 10605744.
14. Wroblewska A, van Haren SD, Herczenik E, Kaijen P, Ruminska A et al. (2012) Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice. Blood 119: 5294-5300. doi:10.1182/blood- 2011-11-391680. PubMed: 22498747.
15. Herczenik E, van Haren SD, Wroblewska A, Kaijen P, van den Biggelaar M et al. (2012) Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain. J Allergy Clin Immunol 129: 501-509, e501-505 doi:10.1016/j.jaci.2011.08.029. PubMed: 21962992.
16. Yates JR 3rd, Eng JK, McCormack AL, Schieltz D (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67: 1426-1436. doi:10.1021/ac00104a020. PubMed: 7741214.
17. Robertson JM, Jensen PE, Evavold BD (2000) DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol 164: 4706-4712. PubMed: 10779776. (Pubitemid 30238071)
18. Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alphaand beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76: 34-40. doi:10.1046/j.1440-1711.1998.00709.x. PubMed: 9553774. (Pubitemid 28194695)
19. Jones TD, Phillips WJ, Smith BJ, Bamford CA, Nayee PD et al. (2005) Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII. J Thromb Haemost 3: 991-1000. doi:10.1111/j.1538-7836. 2005.01309.x. PubMed: 15869596. (Pubitemid 41632831)
20. Jacquemin M, Vantomme V, Buhot C, Lavend'homme R, Burny W et al. (2003) CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A. Blood 101: 1351-1358. doi:10.1182/blood-2002-05-1369. PubMed: 12393451. (Pubitemid 36182506)
21. Pratt KP, Qian J, Ellaban E, Okita DK, Diethelm-Okita BM et al. (2004) Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site. Thromb Haemost 92: 522-528. PubMed: 15351848. (Pubitemid 39255359)
22. James EA, Kwok WW, Ettinger RA, Thompson AR, Pratt KP (2007) Tcell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide. J Thromb Haemost 5: 2399-2407. doi:10.1111/j.1538-7836.2007.02762.x. PubMed: 18034765. (Pubitemid 350154349)
23. Ettinger RA, James EA, Kwok WW, Thompson AR, Pratt KP (2010) HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P. Haemophilia 16: 44-55. doi:10.1111/j.1365-2516.2008.01905.x. PubMed: 20536985.
24. Steinitz KN, van Helden PM, Binder B, Wraith DC, Unterthurner S et al. (2012) CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice. Blood 119: 4073-4082. doi:10.1182/blood-2011-08- 374645. PubMed: 22394599.
25. Wroblewska A, Reipert BM, Pratt KP, Voorberg J (2012) Dangerous liaisons: how the immune system deals with factor VIII. J Thromb Haemost 12: 12065.
26. Beck H, Schwarz G, Schröter CJ, Deeg M, Baier D et al. (2001) Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol 31: 3726-3736. doi:10.1002/1521-4141(200112)31:12. PubMed: 11745393. (Pubitemid 34030986)
27. Belizaire R, Unanue ER (2009) Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A 106: 17463-17468. doi:10.1073/pnas.0908583106. PubMed: 19805168.
28. Burster T, Beck A, Poeschel S, Øren A, Baechle D et al. (2007) Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro. Immunology 121: 82-93. doi:10.1111/j.1365-2567.2007.02540.x. PubMed: 17302735. (Pubitemid 46537666)
29. Burster T, Reich M, Zaidi N, Voelter W, Boehm BO et al. (2008) Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. Biochem Biophys Res Commun 377: 1299-1303. doi:10.1016/j.bbrc.2008.10.162. PubMed: 18996084.
30. Fiebiger E, Meraner P, Weber E, Fang IF, Stingl G et al. (2001) Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med 193: 881-892. doi:10.1084/jem.193.8.881. PubMed: 11304549. (Pubitemid 32525861)
31. Qadura M, Othman M, Waters B, Chegeni R, Walker K et al. (2008) Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells. J Thromb Haemost 6: 2095-2104. doi:10.1111/j.1538-7836.2008.03165.x. PubMed: 18826393.
32. Ragni MV, Wu W, Liang X, Hsieh CC, Cortese-Hassett A et al. (2009) Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. Exp Hematol 37: 744-754. doi:10.1016/j.exphem.2009.02. 011. PubMed: 19463774.
33. Wilson NS, El-Sukkari D, Villadangos JA (2004) Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103: 2187-2195. doi:10.1182/blood-2003-08-2729. PubMed: 14604956. (Pubitemid 38326237)
34. Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T et al. (2008) Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol 9: 1244-1252. doi:10.1038/ni.1665. PubMed: 18849989.
35. van Montfoort N, Camps MG, Khan S, Filippov DV, Weterings JJ et al. (2009) Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A 106: 6730-6735. doi:10.1073/pnas.0900969106. PubMed: 19346487.
36. Walseng E, Furuta K, Goldszmid RS, Weih KA, Sher A et al. (2010) Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J Biol Chem 285: 41749-41754. doi:10.1074/jbc.M110.157586. PubMed: 21047782.
37. Goldstein OG, Hajiaghamohseni LM, Amria S, Sundaram K, Reddy SV et al. (2008) Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother 57: 1461-1470. doi:10.1007/s00262-008-0483-8. PubMed: 18343923.
38. Gocheva V, Wang HW, Gadea BB, Shree T, Hunter KE et al. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24: 241-255. doi:10.1101/gad.1874010. PubMed: 20080943.
39. Creasy BM, McCoy KL (2011) Cytokines regulate cysteine cathepsins during TLR responses. Cell Immunol 267: 56-66. doi:10.1016/j.cellimm.2010.11.004. PubMed: 21145045.
40. Moise L, Song C, Martin WD, Tassone R, De Groot AS et al. (2011) Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo. Clin Immunol, 142: 320-31. PubMed: 22222093.